Evaluating Chronic Lymphocytic Leukemia with Microarray Analysis
Author Information
Author(s): Roger A Schultz, Maria Delioukina, Karl Gaal, Victoria Bedell, David D Smith, Stephen J Forman, Lisa D McDaniel, Blake C Ballif, Lisa G Shaffer, Marilyn L Slovak
Primary Institution: Signature Genomics
Hypothesis
Can BAC-based microarray analysis improve the detection of genetic abnormalities in chronic lymphocytic leukemia (CLL)?
Conclusion
Microarray analysis successfully identified additional genetic abnormalities in CLL cases that were not detected by traditional methods.
Supporting Evidence
- Microarray analysis detected all copy number imbalances identified by prior cytogenetic studies in 15 out of 25 cases.
- Additional abnormalities were found in 15 cases, including deletions linked to CLL susceptibility.
- Microarray analysis was able to detect abnormalities present in as few as 10% of cells.
Takeaway
Researchers looked at 25 patients with a type of blood cancer called CLL and found that a special test could spot more genetic problems than older tests.
Methodology
The study used BAC-based microarray comparative genomic hybridization (aCGH) to analyze genetic samples from patients with CLL.
Potential Biases
The study may be biased towards more severe cases of CLL due to the patient selection from a tertiary care center.
Limitations
Some abnormalities were not detected due to low levels of representation in the samples.
Participant Demographics
Patients diagnosed with chronic lymphocytic leukemia from a tertiary cancer center.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website